Detection of humoral response in patients with glioblastoma receiving EGFRvIII-KLH vaccines

Journal of Immunological Methods

Volumn 339, Issue 1, 2008, Pages 74-81

  Schmittling, Robert J ^a   Archer, Gary E ^a   Mitchell, Duane A ^a   Heimberger, Amy ^b   Pegram, Charles ^a   Herndon II, James E ^a   Friedman, Henry S ^a   Bigner, Darell D ^a   Sampson, John H ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Beads; EGFRvIII; Glioblastoma; Humoral response; KLH; Magnetic; PEPIII

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; EPIDERMAL GROWTH FACTOR RECEPTOR VIII; KEYHOLE LIMPET HEMOCYANIN; KEYHOLE LIMPET HEMOCYANIN ANTIBODY; PEPTIDE VACCINE; PEPTIDE VIII; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY ISOLATION; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG CONJUGATION; DRUG EFFECT; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOASSAY; PRIORITY JOURNAL; PROTEIN DOMAIN;

ADJUVANTS, IMMUNOLOGIC; ANTIBODIES, NEOPLASM; ANTIBODY FORMATION; CANCER VACCINES; FEMALE; GLIOBLASTOMA; HEMOCYANIN; HUMANS; MALE; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; VACCINATION;

EID: 53049089002     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2008.08.004     Document Type: Article

References (35)

1. Aldape K.D., Ballman K., Furth A., Buckner J.C., Giannini C., Burger P.C., Scheithauer B.W., Jenkins R.B., James C.D., Aldape K.D., Ballman K., Furth A., Buckner J.C., Giannini C., Burger P.C., Scheithauer B.W., Jenkins R.B., and James C.D. Immunohistochemical detection of EGFRvIII in high malignancy grade astrocytomas and evaluation of prognostic significance. Journal of Neuropathology and Experimental Neurology 63 (2004) 700
2. Batra S.K., Castelino-Prabhu S., Wikstrand C.J., Zhu X., Humphrey P.A., Friedman H.S., Bigner D.D., Batra S.K., Castelino-Prabhu S., Wikstrand C.J., Zhu X., Humphrey P.A., Friedman H.S., and Bigner D.D. Epidermal growth factor ligand-independent, unregulated, cell-transforming potential of a naturally occurring human mutant EGFRvIII gene. Cell Growth & Differentiation 6 (1995) 1251
3. Bigner S.H., Humphrey P.A., Wong A.J., Vogelstein B., Mark J., Friedman H.S., Bigner D.D., Bigner S.H., Humphrey P.A., Wong A.J., Vogelstein B., Mark J., Friedman H.S., and Bigner D.D. Characterization of the epidermal growth factor receptor in human glioma cell lines and xenografts. Cancer Research 50 (1990) 8017
4. Chu C.T., Everiss K.D., Wikstrand C.J., Batra S.K., Kung H.J., Bigner D.D., Chu C.T., Everiss K.D., Wikstrand C.J., Batra S.K., Kung H.J., and Bigner D.D. Receptor dimerization is not a factor in the signalling activity of a transforming variant epidermal growth factor receptor (EGFRvIII). Biochemical Journal 324 (1997) 855
5. Cunningham M.P., Essapen S., Thomas H., Green M., Lovell D.P., Topham C., Marks C., Modjtahedi H., Cunningham M.P., Essapen S., Thomas H., Green M., Lovell D.P., Topham C., Marks C., and Modjtahedi H. Coexpression, prognostic significance and predictive value of EGFR, EGFRvIII and phosphorylated EGFR in colorectal cancer. International Journal of Oncology 27 (2005) 317
6. Dasso J., Lee J., Bach H., and Mage R.G. A comparison of ELISA and flow microsphere-based assays for quantification of immunoglobulins. Journal of Immunological Methods 263 (2002) 23
7. Ekstrand A.J., James C.D., Cavenee W.K., Seliger B., Pettersson R.F., Collins V.P., Ekstrand A.J., James C.D., Cavenee W.K., Seliger B., Pettersson R.F., and Collins V.P. Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo. Cancer Research 51 (1991) 2164
8. Frederick L., Wang X.Y., Eley G., James C.D., Frederick L., Wang X.Y., Eley G., and James C.D. Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas. Cancer Research 60 (2000) 1383
9. Garcia de Palazzo I.E., Adams G.P., Sundareshan P., Wong A.J., Testa J.R., Bigner D.D., Weiner L.M., Garcia de Palazzo I.E., Adams G.P., Sundareshan P., Wong A.J., Testa J.R., Bigner D.D., and Weiner L.M. Expression of mutated epidermal growth factor receptor by non-small cell lung carcinomas. Cancer Research 53 (1993) 3217
10. Ge H., Gong X., Tang C.K., Ge H., Gong X., and Tang C.K. Evidence of high incidence of EGFRvIII expression and coexpression with EGFR in human invasive breast cancer by laser capture microdissection and immunohistochemical analysis. International Journal of Cancer 98 (2002) 357
11. Glass T.R., Ohmura N., and Saiki H. Least detectable concentration and dynamic range of three immunoassay systems using the same antibody. Analytical Chemistry 79 (2007) 1954
12. Heimberger A.B., Archer G.E., Crotty L.E., McLendon R.E., Friedman A.H., Friedman H.S., Bigner D.D., Sampson J.H., Heimberger A.B., Archer G.E., Crotty L.E., McLendon R.E., Friedman A.H., Friedman H.S., Bigner D.D., and Sampson J.H. Dendritic cells pulsed with a tumor-specific peptide induce long-lasting immunity and are effective against murine intracerebral melanoma. Neurosurgery 50 (2002) 158
13. Heimberger A.B., Crotty L.E., Archer G.E., Hess K.R., Wikstrand C.J., Friedman A.H., Friedman H.S., Bigner D.D., and Sampson J.H. Epidermal growth factor receptor VIII peptide vaccination is efficacious against established intracerebral tumors. Clinical Cancer Research 9 (2003) 4247
14. Heimberger A.B., Hlatky R., Suki D., Yang D., Weinberg J., Gilbert M., Sawaya R., and Aldape K. Prognostic effect of epidermal growth factor receptor and EGFRvIII in glioblastoma multiforme patients. Clinical Cancer Research 11 (2005) 1462
15. Heimberger A.B., Suki D., Yang D., Shi W., and Aldape K. The natural history of EGFR and EGFRvIII in glioblastoma patients. Journal of Translational Medicine 3 (2005) 38
16. Horan P.K., and Wheeless Jr. L.L. Quantitative single cell analysis and sorting. Science 198 (1977) 149
17. Humphrey P.A., Wong A.J., Vogelstein B., Zalutsky M.R., Fuller G.N., Archer G.E., Friedman H.S., Kwatra M.M., Bigner S.H., Bigner D.D., Humphrey P.A., Wong A.J., Vogelstein B., Zalutsky M.R., Fuller G.N., Archer G.E., Friedman H.S., Kwatra M.M., Bigner S.H., and Bigner D.D. Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma. Proceedings of the National Academy of Sciences of the United States of America 87 (1990) 4207
18. Korver K., Zeijlemaker W.P., Schellekens P.T., and Vossen J.M. Measurement of primary in vivo IgM- and IgG-antibody response to KLH in humans: implications of pre-immune IgM binding in antigen-specific ELISA. Journal of Immunological Methods 74 (1984) 241
19. Lal A., Glazer C.A., Martinson H.M., Friedman H.S., Archer G.E., Sampson J.H., Riggins G.J., Lal A., Glazer C.A., Martinson H.M., Friedman H.S., Archer G.E., Sampson J.H., and Riggins G.J. Mutant epidermal growth factor receptor up-regulates molecular effectors of tumor invasion. Cancer Research 62 (2002) 3335
20. Libermann T.A., Nusbaum H.R., Razon N., Kris R., Lax I., Soreq H., Whittle N., Waterfield M.D., Ullrich A., Schlessinger J., Libermann T.A., Nusbaum H.R., Razon N., Kris R., Lax I., Soreq H., Whittle N., Waterfield M.D., Ullrich A., and Schlessinger J. Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin. Nature 313 (1985) 144
21. Luo X., Gong X., Tang C.K., Luo X., Gong X., and Tang C.K. Suppression of EGFRvIII-mediated proliferation and tumorigenesis of breast cancer cells by ribozyme. International Journal of Cancer 104 (2003) 716
22. McHugh T.M., Wang Y.J., Chong H.O., Blackwood L.L., and Stites D.P. Development of a microsphere-based fluorescent immunoassay and its comparison to an enzyme immunoassay for the detection of antibodies to three antigen preparations from Candida albicans. Journal of Immunological Methods 116 (1989) 213
23. Moscatello D.K., Holgado-Madruga M., Godwin A.K., Ramirez G., Gunn G., Zoltick P.W., Biegel J.A., Hayes R.L., Wong A.J., Moscatello D.K., Holgado-Madruga M., Godwin A.K., Ramirez G., Gunn G., Zoltick P.W., Biegel J.A., Hayes R.L., and Wong A.J. Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors. Cancer Research 55 (1995) 5536
24. Nishikawa R., Ji X.D., Harmon R.C., Lazar C.S., Gill G.N., Cavenee W.K., Huang H.J., Nishikawa R., Ji X.D., Harmon R.C., Lazar C.S., Gill G.N., Cavenee W.K., and Huang H.J. A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. Proceedings of the National Academy of Sciences of the United States of America 91 (1994) 7727
25. Nolan J.P., and Sklar L.A. The emergence of flow cytometry for sensitive, real-time measurements of molecular interactions. Nature Biotechnology 16 (1998) 633
26. Okamoto I., Kenyon L.C., Emlet D.R., Mori T., Sasaki J., Hirosako S., Ichikawa Y., Kishi H., Godwin A.K., Yoshioka M., Suga M., Matsumoto M., and Wong A.J. Expression of constitutively activated EGFRvIII in non-small cell lung cancer. Cancer Science 94 (2003) 50
27. Olapade-Olaopa E.O., Moscatello D.K., MacKay E.H., Horsburgh T., Sandhu D.P., Terry T.R., Wong A.J., Habib F.K., Olapade-Olaopa E.O., Moscatello D.K., MacKay E.H., Horsburgh T., Sandhu D.P., Terry T.R., Wong A.J., and Habib F.K. Evidence for the differential expression of a variant EGF receptor protein in human prostate cancer. British Journal of Cancer 82 (2000) 186
28. Ooi K.G.J., Galatowicz G., Towler H.M.A., Lightman S.L., and Calder V.L. Multiplex cytokine detection versus ELISA for aqueous humor: IL-5, IL-10, and IFNgamma profiles in uveitis. Investigative Ophthalmology & Visual Science 47 (2006) 272
29. Pelloski C.E., Ballman K.V., Furth A.F., Zhang L., Lin E., Sulman E.P., Bhat K., McDonald J.M., Yung W.K.A., Colman H., Woo S.Y., Heimberger A.B., Suki D., Prados M.D., Chang S.M., Barker II F.G., Buckner J.C., James C.D., and Aldape K. Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastoma. Journal of Clinical Oncology 25 (2007) 2288
30. Purev E., Cai D., Miller E., Swoboda R., Mayer T., Klein-Szanto A., Marincola F.M., Mick R., Otvos L., Wunner W., Birebent B., Somasundaram R., Wikstrand C.J., Bigner D., DeMichele A., Acs G., Berlin J.A., and Herlyn D. Immune responses of breast cancer patients to mutated epidermal growth factor receptor (EGF-RvIII, Delta EGF-R, and de2-7 EGF-R). Journal of Immunology 173 (2004) 6472
31. Sugawa N., Ekstrand A.J., James C.D., Collins V.P., Sugawa N., Ekstrand A.J., James C.D., and Collins V.P. Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas. Proceedings of the National Academy of Sciences of the United States of America 87 (1990) 8602
32. Vignali D.A. Multiplexed particle-based flow cytometric assays. Journal of Immunological Methods 243 (2000) 243
33. Wikstrand C.J., Hale L.P., Batra S.K., Hill M.L., Humphrey P.A., Kurpad S.N., McLendon R.E., Moscatello D., Pegram C.N., Reist C.J., et al. Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas. Cancer Research 55 (1995) 3140
34. Wilson R., Clavering C., and Hutchinson A. Paramagnetic bead based enzyme electrochemiluminescence immunoassay for TNT. Journal of Electroanalytical Chemistry 557 (2003) 109
35. Wong A.J., Ruppert J.M., Bigner S.H., Grzeschik C.H., Humphrey P.A., Bigner D.S., Vogelstein B., Wong A.J., Ruppert J.M., Bigner S.H., Grzeschik C.H., Humphrey P.A., Bigner D.S., and Vogelstein B. Structural alterations of the epidermal growth factor receptor gene in human gliomas. Proceedings of the National Academy of Sciences of the United States of America 89 (1992) 2965